Transdermal Skin Patches Market - Global Outlook and Forecast 2022-2028

Transdermal Skin Patches Market - Global Outlook and Forecast 2022-2028

Report Code: KNJ1156358 | No. of Pages: 74 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Jan-2022
This report contains market size and forecasts of Transdermal Skin Patches in global, including the following market information:
Global Transdermal Skin Patches Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Transdermal Skin Patches Market Sales, 2017-2022, 2023-2028, (M Pcs)
Global top five Transdermal Skin Patches companies in 2021 (%)
The global Transdermal Skin Patches market was valued at 43 million in 2021 and is projected to reach US$ 51 million by 2028, at a CAGR of 2.6% during the forecast period.
The U.S. Market is Estimated at $  Million in 2021, While China is Forecast to Reach $  Million by 2028.
Drug in Adhesive Segment to Reach $  Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Transdermal Skin Patches include Johnson & Johnson, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries, Luye Pharma Group, Hisamitsu Pharmaceutical, Mundipharma International and Purdue Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Transdermal Skin Patches manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Transdermal Skin Patches Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)
Global Transdermal Skin Patches Market Segment Percentages, by Type, 2021 (%)
    Drug in Adhesive
    Matrix
    Reservoir
    Vapor
    Others
Global Transdermal Skin Patches Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)
Global Transdermal Skin Patches Market Segment Percentages, by Application, 2021 (%)
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies
Global Transdermal Skin Patches Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)
Global Transdermal Skin Patches Market Segment Percentages, By Region and Country, 2021 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Transdermal Skin Patches revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Transdermal Skin Patches revenues share in global market, 2021 (%)
Key companies Transdermal Skin Patches sales in global market, 2017-2022 (Estimated), (M Pcs)
Key companies Transdermal Skin Patches sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Johnson & Johnson
    Novartis AG
    Mylan N.V.
    Teva Pharmaceutical Industries
    Luye Pharma Group
    Hisamitsu Pharmaceutical
    Mundipharma International
    Purdue Pharma
1 Introduction to Research & Analysis Reports
    1.1 Transdermal Skin Patches Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Transdermal Skin Patches Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Transdermal Skin Patches Overall Market Size
    2.1 Global Transdermal Skin Patches Market Size: 2021 VS 2028
    2.2 Global Transdermal Skin Patches Revenue, Prospects & Forecasts: 2017-2028
    2.3 Global Transdermal Skin Patches Sales: 2017-2028
3 Company Landscape
    3.1 Top Transdermal Skin Patches Players in Global Market
    3.2 Top Global Transdermal Skin Patches Companies Ranked by Revenue
    3.3 Global Transdermal Skin Patches Revenue by Companies
    3.4 Global Transdermal Skin Patches Sales by Companies
    3.5 Global Transdermal Skin Patches Price by Manufacturer (2017-2022)
    3.6 Top 3 and Top 5 Transdermal Skin Patches Companies in Global Market, by Revenue in 2021
    3.7 Global Manufacturers Transdermal Skin Patches Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Transdermal Skin Patches Players in Global Market
        3.8.1 List of Global Tier 1 Transdermal Skin Patches Companies
        3.8.2 List of Global Tier 2 and Tier 3 Transdermal Skin Patches Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Transdermal Skin Patches Market Size Markets, 2021 & 2028
        4.1.2 Drug in Adhesive
        4.1.3 Matrix
        4.1.4 Reservoir
        4.1.5 Vapor
        4.1.6 Others
    4.2 By Type - Global Transdermal Skin Patches Revenue & Forecasts
        4.2.1 By Type - Global Transdermal Skin Patches Revenue, 2017-2022
        4.2.2 By Type - Global Transdermal Skin Patches Revenue, 2023-2028
        4.2.3 By Type - Global Transdermal Skin Patches Revenue Market Share, 2017-2028
    4.3 By Type - Global Transdermal Skin Patches Sales & Forecasts
        4.3.1 By Type - Global Transdermal Skin Patches Sales, 2017-2022
        4.3.2 By Type - Global Transdermal Skin Patches Sales, 2023-2028
        4.3.3 By Type - Global Transdermal Skin Patches Sales Market Share, 2017-2028
    4.4 By Type - Global Transdermal Skin Patches Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
    5.1 Overview
        5.1.1 By Application - Global Transdermal Skin Patches Market Size, 2021 & 2028
        5.1.2 Hospital Pharmacies
        5.1.3 Retail Pharmacies
        5.1.4 Online Pharmacies
    5.2 By Application - Global Transdermal Skin Patches Revenue & Forecasts
        5.2.1 By Application - Global Transdermal Skin Patches Revenue, 2017-2022
        5.2.2 By Application - Global Transdermal Skin Patches Revenue, 2023-2028
        5.2.3 By Application - Global Transdermal Skin Patches Revenue Market Share, 2017-2028
    5.3 By Application - Global Transdermal Skin Patches Sales & Forecasts
        5.3.1 By Application - Global Transdermal Skin Patches Sales, 2017-2022
        5.3.2 By Application - Global Transdermal Skin Patches Sales, 2023-2028
        5.3.3 By Application - Global Transdermal Skin Patches Sales Market Share, 2017-2028
    5.4 By Application - Global Transdermal Skin Patches Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
    6.1 By Region - Global Transdermal Skin Patches Market Size, 2021 & 2028
    6.2 By Region - Global Transdermal Skin Patches Revenue & Forecasts
        6.2.1 By Region - Global Transdermal Skin Patches Revenue, 2017-2022
        6.2.2 By Region - Global Transdermal Skin Patches Revenue, 2023-2028
        6.2.3 By Region - Global Transdermal Skin Patches Revenue Market Share, 2017-2028
    6.3 By Region - Global Transdermal Skin Patches Sales & Forecasts
        6.3.1 By Region - Global Transdermal Skin Patches Sales, 2017-2022
        6.3.2 By Region - Global Transdermal Skin Patches Sales, 2023-2028
        6.3.3 By Region - Global Transdermal Skin Patches Sales Market Share, 2017-2028
    6.4 North America
        6.4.1 By Country - North America Transdermal Skin Patches Revenue, 2017-2028
        6.4.2 By Country - North America Transdermal Skin Patches Sales, 2017-2028
        6.4.3 US Transdermal Skin Patches Market Size, 2017-2028
        6.4.4 Canada Transdermal Skin Patches Market Size, 2017-2028
        6.4.5 Mexico Transdermal Skin Patches Market Size, 2017-2028
    6.5 Europe
        6.5.1 By Country - Europe Transdermal Skin Patches Revenue, 2017-2028
        6.5.2 By Country - Europe Transdermal Skin Patches Sales, 2017-2028
        6.5.3 Germany Transdermal Skin Patches Market Size, 2017-2028
        6.5.4 France Transdermal Skin Patches Market Size, 2017-2028
        6.5.5 U.K. Transdermal Skin Patches Market Size, 2017-2028
        6.5.6 Italy Transdermal Skin Patches Market Size, 2017-2028
        6.5.7 Russia Transdermal Skin Patches Market Size, 2017-2028
        6.5.8 Nordic Countries Transdermal Skin Patches Market Size, 2017-2028
        6.5.9 Benelux Transdermal Skin Patches Market Size, 2017-2028
    6.6 Asia
        6.6.1 By Region - Asia Transdermal Skin Patches Revenue, 2017-2028
        6.6.2 By Region - Asia Transdermal Skin Patches Sales, 2017-2028
        6.6.3 China Transdermal Skin Patches Market Size, 2017-2028
        6.6.4 Japan Transdermal Skin Patches Market Size, 2017-2028
        6.6.5 South Korea Transdermal Skin Patches Market Size, 2017-2028
        6.6.6 Southeast Asia Transdermal Skin Patches Market Size, 2017-2028
        6.6.7 India Transdermal Skin Patches Market Size, 2017-2028
    6.7 South America
        6.7.1 By Country - South America Transdermal Skin Patches Revenue, 2017-2028
        6.7.2 By Country - South America Transdermal Skin Patches Sales, 2017-2028
        6.7.3 Brazil Transdermal Skin Patches Market Size, 2017-2028
        6.7.4 Argentina Transdermal Skin Patches Market Size, 2017-2028
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Transdermal Skin Patches Revenue, 2017-2028
        6.8.2 By Country - Middle East & Africa Transdermal Skin Patches Sales, 2017-2028
        6.8.3 Turkey Transdermal Skin Patches Market Size, 2017-2028
        6.8.4 Israel Transdermal Skin Patches Market Size, 2017-2028
        6.8.5 Saudi Arabia Transdermal Skin Patches Market Size, 2017-2028
        6.8.6 UAE Transdermal Skin Patches Market Size, 2017-2028
7 Manufacturers & Brands Profiles
    7.1 Johnson & Johnson
        7.1.1 Johnson & Johnson Corporate Summary
        7.1.2 Johnson & Johnson Business Overview
        7.1.3 Johnson & Johnson Transdermal Skin Patches Major Product Offerings
        7.1.4 Johnson & Johnson Transdermal Skin Patches Sales and Revenue in Global (2017-2022)
        7.1.5 Johnson & Johnson Key News
    7.2 Novartis AG
        7.2.1 Novartis AG Corporate Summary
        7.2.2 Novartis AG Business Overview
        7.2.3 Novartis AG Transdermal Skin Patches Major Product Offerings
        7.2.4 Novartis AG Transdermal Skin Patches Sales and Revenue in Global (2017-2022)
        7.2.5 Novartis AG Key News
    7.3 Mylan N.V.
        7.3.1 Mylan N.V. Corporate Summary
        7.3.2 Mylan N.V. Business Overview
        7.3.3 Mylan N.V. Transdermal Skin Patches Major Product Offerings
        7.3.4 Mylan N.V. Transdermal Skin Patches Sales and Revenue in Global (2017-2022)
        7.3.5 Mylan N.V. Key News
    7.4 Teva Pharmaceutical Industries
        7.4.1 Teva Pharmaceutical Industries Corporate Summary
        7.4.2 Teva Pharmaceutical Industries Business Overview
        7.4.3 Teva Pharmaceutical Industries Transdermal Skin Patches Major Product Offerings
        7.4.4 Teva Pharmaceutical Industries Transdermal Skin Patches Sales and Revenue in Global (2017-2022)
        7.4.5 Teva Pharmaceutical Industries Key News
    7.5 Luye Pharma Group
        7.5.1 Luye Pharma Group Corporate Summary
        7.5.2 Luye Pharma Group Business Overview
        7.5.3 Luye Pharma Group Transdermal Skin Patches Major Product Offerings
        7.5.4 Luye Pharma Group Transdermal Skin Patches Sales and Revenue in Global (2017-2022)
        7.5.5 Luye Pharma Group Key News
    7.6 Hisamitsu Pharmaceutical
        7.6.1 Hisamitsu Pharmaceutical Corporate Summary
        7.6.2 Hisamitsu Pharmaceutical Business Overview
        7.6.3 Hisamitsu Pharmaceutical Transdermal Skin Patches Major Product Offerings
        7.6.4 Hisamitsu Pharmaceutical Transdermal Skin Patches Sales and Revenue in Global (2017-2022)
        7.6.5 Hisamitsu Pharmaceutical Key News
    7.7 Mundipharma International
        7.7.1 Mundipharma International Corporate Summary
        7.7.2 Mundipharma International Business Overview
        7.7.3 Mundipharma International Transdermal Skin Patches Major Product Offerings
        7.7.4 Mundipharma International Transdermal Skin Patches Sales and Revenue in Global (2017-2022)
        7.7.5 Mundipharma International Key News
    7.8 Purdue Pharma
        7.8.1 Purdue Pharma Corporate Summary
        7.8.2 Purdue Pharma Business Overview
        7.8.3 Purdue Pharma Transdermal Skin Patches Major Product Offerings
        7.8.4 Purdue Pharma Transdermal Skin Patches Sales and Revenue in Global (2017-2022)
        7.8.5 Purdue Pharma Key News
8 Global Transdermal Skin Patches Production Capacity, Analysis
    8.1 Global Transdermal Skin Patches Production Capacity, 2017-2028
    8.2 Transdermal Skin Patches Production Capacity of Key Manufacturers in Global Market
    8.3 Global Transdermal Skin Patches Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Transdermal Skin Patches Supply Chain Analysis
    10.1 Transdermal Skin Patches Industry Value Chain
    10.2 Transdermal Skin Patches Upstream Market
    10.3 Transdermal Skin Patches Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Transdermal Skin Patches Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com